martes, 4 de noviembre de 2014

National Guideline Clearinghouse | Guidelines by Topic: Lung Neoplasms

National Guideline Clearinghouse | Guidelines by Topic: Lung Neoplasms



National Guideline Clearinghouse (NGC)



Guidelines by Topic

Lung Neoplasms (65)
Search within:    
Sort results by:      


Filter results by: 
1-20 of 65   Next >
 
1. 
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer. 2014 Apr. NGC:010348
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2. 
Pemetrexed maintenance treatment following induction therapy with pemetrexed and cisplatin for non-squamous non-small-cell lung cancer. 2014 Apr. NGC:010350
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3. 
Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2014 Mar 4). NGC:010192
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)
 
View associated Guideline Synthesis
4. 
Management of lung cancer. A national clinical guideline. 1998 Feb (revised 2014 Feb). NGC:010220
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
6. 
Non-small cell lung cancer stage IV. 2011 Jun (revised 2013 Nov). NGC:010261
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7. 
Lung cancer and cancer of the pleura. In: Pulmonary (acute & chronic). 2009 Jan (revised 2013 Oct 29). NGC:010122
Work Loss Data Institute - For Profit Organization. View all guidelines by the developer(s)
8. 
Crizotinib for previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase fusion gene. 2013 Sep. NGC:010021
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9. 
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors. Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. 2013 Jun. NGC:009787
Association for Molecular Pathology - Medical Specialty Society; College of American Pathologists - Medical Specialty Society; International Association for the Study of Lung Cancer - Disease Specific Society. View all guidelines by the developer(s)
1-20 of 65   Next >



21-40 of 65   < Previous Next >
 
21. 
29. 
Screening high-risk populations for lung cancer. 2013 Apr 18. NGC:010035
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
30. 
American Cancer Society lung cancer screening guidelines. 2013 Mar-Apr. NGC:009686
American Cancer Society - Disease Specific Society. View all guidelines by the developer(s)
 
View associated Guideline Synthesis
31. 
ACR Appropriateness Criteria® early-stage non–small-cell lung cancer. 2013. NGC:010178
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
32. 
ACR Appropriateness Criteria® induction and adjuvant therapy for N2 non–small-cell lung cancer. 1999 (revised 2013). NGC:010179
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
33. 
ACR Appropriateness Criteria® non-invasive clinical staging of bronchogenic carcinoma. 1995 (revised 2013). NGC:010163
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
34. 
ACR Appropriateness Criteria® screening for pulmonary metastases. 1995 (revised 2013). NGC:010164
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
35. 
Non-small cell lung cancer stage III. 2012 Apr. NGC:009399
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
36. 
37. 
ACR Appropriateness Criteria® radiation therapy for small-cell lung cancer. 2012. NGC:009217
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
38. 
ACR Appropriateness Criteria® radiographically detected solitary pulmonary nodule. 1995 (revised 2012). NGC:009227
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
39. 
Superior sulcus (Pancoast) tumours. 2012 Jan. NGC:009390
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
40. 
21-40 of 65   < Previous Next >



41-60 of 65   < Previous Next >
 
42. 
Non-small cell lung cancer stage I. 2011 Jun. NGC:009397
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
43. 
Non-small cell lung cancer stage II. 2011 Jun. NGC:009398
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
44. 
Lung cancer. The diagnosis and treatment of lung cancer. 2005 Feb (revised 2011 Apr). NGC:008662
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
46. 
ACR Appropriateness Criteria® non-spine bone metastases. 1996 (revised 2011). NGC:008877
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
47. 
ACR Appropriateness Criteria® radiologic management of thoracic nodules and masses. 1996 (revised 2011). NGC:008459
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
48. 
The role of IMRT in lung cancer. 2010 Nov 22. NGC:008829
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
49. 
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer. 2010 Jul. NGC:008066
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
50. 
Palliative radiotherapy. 2010 Jul. NGC:008715
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
51. 
First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer. 2009 May 22 (revised 2010 Feb 3). NGC:007692
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
52. 
ACR–ASTRO practice guideline for the performance of high-dose-rate brachytherapy. 1996 (revised 2010). NGC:008423
American College of Radiology - Medical Specialty Society; American Society for Radiation Oncology - Professional Association. View all guidelines by the developer(s)
53. 
ACR–SPR practice guideline for the performance of tumor scintigraphy (with gamma cameras). 1996 (revised 2010). NGC:008421
American College of Radiology - Medical Specialty Society; Society for Pediatric Radiology - Medical Specialty Society. View all guidelines by the developer(s)
54. 
Topotecan for the treatment of relapsed small-cell lung cancer. 2009 Nov. NGC:007620
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
55. 
Pemetrexed for the first-line treatment of non-small-cell lung cancer. 2009 Sep. NGC:007623
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
56. 
PET imaging in small cell lung cancer: recommendations. 2009 Jan 19. NGC:007454
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
58. 
Lung cancer. Practice organization 2003 Jan (reaffirmed 2009 Oct). NGC:002881
American College of Chest Physicians - Medical Specialty Society. View all guidelines by the developer(s)
59. 
60. 
ACR Appropriateness Criteria® single brain metastasis. 1999 (revised 2012). NGC:009678
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
41-60 of 65   < Previous Next >



61-65 of 65   < Previous
 
61. 
ACR Appropriateness Criteria® spinal bone metastases. 1996 (revised 2012). NGC:009677
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
62. 
Role of EUS for the evaluation of mediastinal adenopathy. 2003 Dec (revised 2011 Aug). NGC:009186
American Society for Gastrointestinal Endoscopy - Medical Specialty Society. View all guidelines by the developer(s)
63. 
Metastatic spinal cord compression. Diagnosis and management of adults at risk of and with metastatic spinal cord compression. 2008 Nov (reaffirmed 2012). NGC:007194
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
64. 
Pemetrexed for the maintenance treatment of non-small-cell lung cancer. 2010 Jun. NGC:007913
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
65. 
ACR–ASTRO practice guideline for the performance of low-dose-rate brachytherapy. 1996 (revised 2010). NGC:008424
American College of Radiology - Medical Specialty Society; American Society for Radiation Oncology - Professional Association. View all guidelines by the developer(s)
61-65 of 65   < Previous

No hay comentarios:

Publicar un comentario